January 29, 2020 January 31, 2020
Revere Hotel Boston Common, Boston, MA - USA

PARP & DDR Inhibitors Summit 2020

The DNA Damage Response Therapeutics Summit brings together the leading pharma and biotech companies accelerating DNA repair pathway inhibitors, to optimize drug discovery, broaden patient population and generate greater efficacy.

Download presentation by F. Bono : Introducing OX401, a Next Generation PARP Inhibitor Able to Exploit Metabolic Vulnerabilities of Cancer Cells and Inducing a Potent STING Response

Session: Innovative Approaches to Targeting the DDR, Thursday, January 30, 2019 at 2:30 pm

Download poster : AsiDNA™, a first-in-class, clinical stage “Decoy Agonist” targeting DNA repair pathways 

Poster sessions : Wednesday, January 29 at 3.15 pm and Thursday, January 30 at 10.50 am.

For further information, visit the PARP & DDR Inhibitors Summit 2020 website